GlaxoSmithKline PLC Director/PDMR Shareholding (9402B)
January 15 2018 - 11:54AM
UK Regulatory
TIDMGSK
RNS Number : 9402B
GlaxoSmithKline PLC
15 January 2018
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated
with them ('PCA')
=== ========================================================
a) Name Mr D S Redfern
=== ====================== ================================
b) Position/status Chief Strategy Officer
=== ====================== ================================
c) Initial notification/ Initial notification
amendment
=== ====================== ================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ========================================================
a) Name GlaxoSmithKline plc
=== ====================== ================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ========================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== ================================
b) Nature of Acquisition of Ordinary Shares
the transaction following the re-investment of
dividends paid to shareholders
on 12 January 2018, on shares
held within an ISA.
=== ====================== ================================
c) Price(s) and Price(s) Volume(s)
volume(s) ------------ ----------
GBP13.4755 26
------------ ----------
=== ====================== ================================
d) Aggregated n/a (single transaction)
information
Aggregated
volume Price
=== ====================== ================================
e) Date of the 2018-01-12
transaction
=== ====================== ================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== ================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ========================================================
a) Name Mrs V A Whyte
=== ====================== ================================
b) Position/status Company Secretary
=== ====================== ================================
c) Initial notification/ Initial notification
amendment
=== ====================== ================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ========================================================
a) Name GlaxoSmithKline plc
=== ====================== ================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ========================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== ================================
b) Nature of Acquisition of Ordinary Shares
the transaction following the re-investment of
dividends paid to shareholders
on 12 January 2018, on shares
held within an ISA.
=== ====================== ================================
c) Price(s) and Price(s) Volume(s)
volume(s) ------------ ----------
GBP13.4755 22
------------ ----------
=== ====================== ================================
d) Aggregated n/a (single transaction)
information
Aggregated
volume Price
=== ====================== ================================
e) Date of the 2018-01-12
transaction
=== ====================== ================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== ================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHDELFFVFFEBBL
(END) Dow Jones Newswires
January 15, 2018 12:54 ET (17:54 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024